Stay ahead in medical device compliance with this specialized course on the FDA’s new classification of postnatal chromosomal copy number variation (CNV) detection systems. Discover actionable steps for device manufacturers, laboratories, and regulatory professionals to meet class II requirements, implement special controls, and fulfill strict labeling obligations. Ensure your organization is ready for enhanced patient access and reduced regulatory burden while maintaining high standards of safety and effectiveness.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the postnatal CNV detection system as class II.
* Identify the key special controls and general controls required for compliance.
* Recognize the device’s intended use, limitations, and labeling requirements.
* Implement the necessary steps to ensure regulatory compliance and avoid legal or financial penalties.
